Biopharmaceuticals
Cardiology
News Release - August 28, 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Source: The Medicines Company
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
